385 results on '"Hayden, Frederick G"'
Search Results
2. Oral Favipiravir Exposure and Pharmacodynamic Effects in Adult Outpatients With Acute Influenza.
3. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
4. Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
5. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis
6. Critical care management of adults with community-acquired severe respiratory viral infection
7. Macrolides in critically ill patients with Middle East Respiratory Syndrome
8. Ebola virus disease: an update on post-exposure prophylaxis
9. Cardiac Findings during Uncomplicated Acute Influenza in Ambulatory Adults
10. Experimental Therapies for Ebola Virus Disease: What Have We Learned?
11. Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia
12. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
13. Perspectives on Antiviral Use during Pandemic Influenza
14. The Immunogenicity of Influenza Virus Vaccine in Solid Organ Transplant Recipients
15. Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential
16. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia
17. Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
18. EDITORIAL COMMENTARY: Host and Viral Factors in Emergent Influenza Virus Infections
19. Short-Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo-Controlled Study
20. Editorial Response: Rhinovirus Pneumonia: A Clinical Entity?
21. Enterovirus Meningitis in Adults
22. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
23. The Beneficial Effects of Neuraminidase Inhibitor Drug Therapy on Severe Patient Outcomes During the 2009—2010 Influenza A Virus Subtype H1N1 Pandemic
24. Combination Antiviral Therapy for Influenza: Predictions From Modeling of Human Infections
25. Fatal Influenza B Infections: Time to Reexamine Influenza Research Priorities
26. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
27. Emerging Influenza Antiviral Resistance Threats
28. End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease
29. "Prepandemic" Immunization for Novel Influenza Viruses, "Swine Flu" Vaccine, Guillain-Barré Syndrome, and the Detection of Rare Severe Adverse Events
30. Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
31. Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals
32. Preventing the Airborne Spread of Staphylococcus aureus by Persons With the Common Cold: Effect of Surgical Scrubs, Gowns, and Masks
33. John F. Enders Lecture 2006: Antivirals for Influenza
34. Seasonal and Pandemic Influenza: Recommendations for Preparedness in the United States
35. Antiviral Management of Seasonal and Pandemic Influenza
36. "Gesundheit!" Sneezing, Common Colds, Allergies, and Staphylococcus aureus Dispersion
37. Comparative Activities of Oseltamivir and A-322278 in Immunocompetent and Immunocompromised Murine Models of Influenza Virus Infection
38. Recovery of Drug-Resistant Influenza Virus from Immunocompromised Patients: A Case Series
39. Influenza Treatment with Neuraminidase Inhibitors: Cost-Effectiveness and Cost-Utility in Healthy Adults in the United Kingdom
40. Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
41. Preventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of Clinicians
42. Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment with or without Postexposure Prophylaxis
43. Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials
44. Assessment of Hemagglutinin Sequence Heterogeneity during Influenza Virus Transmission in Families
45. Rhinovirus and Coronavirus Infection-Associated Hospitalizations among Older Adults
46. Accumulation of Defective Neuraminidase (NA) Genes by Influenza a Viruses in the Presence of NA Inhibitors as a Marker of Reduced Dependence on NA
47. Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
48. Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine
49. Nasal Cytokine and Chemokine Responses in Experimental Influenza a Virus Infection: Results of a Placebo-Controlled Trial of Intravenous Zanamivir Treatment
50. Overview of the 3rd isirv-Antiviral Group Conference – advances in clinical management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.